2-Amino-5-Methylphenol for Antihistamine Precursors: Impurity Profiles
Technical Specifications and Purity Grades of 2-Amino-5-methylphenol for Antihistamine Synthesis
In the synthesis of antihistamine precursors, 2-amino-5-methylphenol (CAS 2835-98-5) serves as a critical building block. This compound, also known as 4-methyl-1-amino-2-hydroxybenzene or 5-methyl-2-aminophenol, is valued for its role in constructing heterocyclic scaffolds that modulate histamine receptors. For procurement managers and QA directors, understanding the technical grade and purity specifications is paramount. Industrial purity typically exceeds 98%, but for pharmaceutical applications, a purity of 99% or higher is often required to minimize side reactions and ensure consistent API quality. The manufacturing process involves a controlled synthesis route starting from m-cresol, followed by nitration, reduction, and purification steps. Key parameters include melting point (148–152°C), appearance (off-white to light brown crystalline powder), and solubility in common organic solvents. However, the true differentiator in bulk procurement lies in the impurity profile, particularly the presence of positional isomers and trace amines that can impact downstream reactions.
One non-standard parameter that field experience has highlighted is the viscosity shift of molten 2-amino-5-methylphenol at sub-zero temperatures during storage and transport. In colder climates, the material can exhibit increased viscosity, which may affect handling and pumping if not properly temperature-controlled. This behavior is rarely documented in standard specifications but is crucial for logistics planning. Additionally, trace impurities such as 2-amino-4-methylphenol can affect the color of the final product, leading to off-white or slightly pinkish hues that may be unacceptable for certain pharmaceutical formulations. Our team has observed that maintaining strict control over the nitration step minimizes these color-forming impurities, ensuring batch-to-batch consistency.
| Parameter | Technical Grade | Pharmaceutical Grade |
|---|---|---|
| Purity (HPLC) | ≥98.0% | ≥99.5% |
| Melting Point | 148–152°C | 149–151°C |
| Isomer Impurity (2-amino-4-methylphenol) | ≤1.0% | ≤0.3% |
| Loss on Drying | ≤0.5% | ≤0.2% |
| Residue on Ignition | ≤0.2% | ≤0.1% |
For antihistamine precursor synthesis, the pharmaceutical grade is recommended to avoid interference from trace amines that could act as false transmitters or disrupt receptor binding assays. As discussed in the literature, trace amines like tyramine and β-phenylethylamine can accumulate when amine degradation pathways are blocked, leading to significant biological effects. Thus, controlling these impurities at the intermediate stage is a proactive quality measure. Our 2-amino-5-methylphenol is manufactured under strict process controls to meet these exacting standards, ensuring a drop-in replacement for your current supplier with identical technical parameters and enhanced cost-efficiency.
Trace Amine Impurity Profiles: Isomeric Amines and Their Impact on HPLC Resolution
The trace amine impurity profile of 2-amino-5-methylphenol is a critical quality attribute that directly influences HPLC resolution and, consequently, the purity of the final antihistamine API. The primary isomeric impurity is 2-amino-4-methylphenol (also known as 2-amino-1-hydroxy-5-methyl-benzene), which differs only in the position of the methyl group. This isomer can co-elute with the main peak under standard reversed-phase conditions, leading to inaccurate purity assessments. To achieve baseline separation, procurement teams should specify an HPLC method using a C18 column with a mobile phase of methanol and phosphate buffer (pH 3.0) at a flow rate of 1.0 mL/min, with UV detection at 254 nm. Under these conditions, the relative retention time of the isomer is approximately 1.2, allowing for reliable quantification.
Beyond the positional isomer, other trace amines such as 2-amino-5-ethylphenol or residual starting materials can appear as minor peaks. These impurities, even at levels below 0.1%, can act as pharmacologically active trace amines if carried through to the final API. For example, β-phenylethylamine is a known trace amine that modulates dopaminergic transmission, and its presence as an impurity could confound in vitro receptor binding studies. Therefore, a robust impurity profile is not merely a regulatory requirement but a functional necessity for drug developers. Our experience shows that batches with isomer content above 0.5% often exhibit reduced crystallization yields in the final API step, likely due to disruption of the crystal lattice. This field observation underscores the importance of tight isomer control, which we achieve through optimized recrystallization from toluene/hexane mixtures. For further insights into how iron content can affect synthesis, see our article on iron content limits in 2-amino-5-methylphenol for agrochemical synthesis.
COA-Driven Batch Acceptance: Mapping Impurity Thresholds to API Crystallization Yield
For QA directors, the Certificate of Analysis (COA) is the definitive document for batch acceptance. When sourcing 2-amino-5-methylphenol for antihistamine precursors, the COA must detail not only the main assay but also the individual impurity levels. A typical COA will list purity by HPLC, melting point, loss on drying, residue on ignition, and specific impurity limits. However, the critical parameter that often determines batch acceptance is the isomer ratio. Based on our internal studies, an isomer content below 0.3% correlates with a crystallization yield of over 85% in the final API step, while batches with 0.5–1.0% isomer show yields dropping to 70–75%. This is because the isomeric impurity can incorporate into the growing crystal, causing defects and requiring additional recrystallization cycles.
Another edge-case behavior we have documented is the tendency of 2-amino-5-methylphenol to form dimers or oligomers upon prolonged storage at elevated temperatures. These high-molecular-weight impurities are not always captured by standard HPLC methods but can be detected by gel permeation chromatography. They can act as nucleation inhibitors, further reducing crystallization efficiency. Therefore, we recommend that procurement teams include a clause for cold chain storage (2–8°C) for long-term inventory, especially for pharmaceutical-grade material. When a COA shows borderline results, a batch hold protocol should be implemented, including re-testing after 3 months and small-scale crystallization trials before full-scale use. This proactive approach minimizes production risks and ensures supply chain reliability. For a related discussion on formulation challenges, refer to our article on 2-amino-5-methylphenol in oxidative hair dye coupler formulation.
Bulk Packaging and Supply Chain Integrity for Procurement Teams
Bulk packaging of 2-amino-5-methylphenol is designed to maintain chemical integrity during transit and storage. Standard packaging options include 25 kg fiber drums with inner PE liners, 210L steel drums for larger quantities, and 1000L IBC totes for high-volume users. The material is hygroscopic and light-sensitive, so packaging must provide a moisture barrier and UV protection. For pharmaceutical-grade material, we recommend double-bagging under nitrogen to prevent oxidation. Logistics considerations include compliance with dangerous goods regulations for air and sea freight, as the compound is classified as an irritant. Our supply chain is optimized for global delivery, with warehousing in key ports to reduce lead times. We do not claim EU REACH compliance, but our packaging meets international standards for physical protection and segregation.
Procurement managers should also consider the total cost of ownership, including demurrage and customs clearance. By partnering with a manufacturer that offers flexible packaging and just-in-time delivery, you can reduce inventory carrying costs. Our drop-in replacement strategy ensures that our 2-amino-5-methylphenol matches the specifications of your current supplier, allowing for seamless qualification with minimal paperwork. The global manufacturer landscape is competitive, but our focus on consistent quality and technical support sets us apart. Please refer to the batch-specific COA for exact numerical specifications, as data may vary slightly between production runs.
Frequently Asked Questions
What HPLC column is recommended for separating 2-amino-5-methylphenol from its positional isomers?
A C18 column (250 mm × 4.6 mm, 5 µm) with a mobile phase of methanol and 0.05 M phosphate buffer (pH 3.0) at a ratio of 40:60 provides good resolution. The isomer typically elutes at a relative retention time of 1.2. For critical separations, a phenyl-hexyl column may offer enhanced selectivity.
What are the acceptable isomer ratios per pharmacopeial standards?
While no specific pharmacopeial monograph exists for this intermediate, industry standards for pharmaceutical-grade material typically require the 2-amino-4-methylphenol isomer to be ≤0.3%. For technical grade, ≤1.0% is common. Always refer to the supplier's COA and your internal specifications.
What batch hold protocols are recommended for borderline COA results?
If a batch shows isomer content near the upper limit or unexpected impurity peaks, we recommend a hold-and-test protocol: store the batch at 2–8°C, re-analyze after 3 months for stability, and perform a small-scale crystallization trial with your API process. If the yield and purity are acceptable, the batch can be released for production.
What is the common name for 2 isopropyl 5 Methylphenol?
The common name for 2-isopropyl-5-methylphenol is thymol, a natural monoterpene phenol found in thyme essential oil. It is not directly related to 2-amino-5-methylphenol but shares a similar substitution pattern on the phenol ring.
What is the precursor amino acid for histamine?
Histamine is synthesized from the amino acid L-histidine via decarboxylation catalyzed by histidine decarboxylase. This is a key step in the biosynthesis of histamine, a biogenic amine involved in immune responses and neurotransmission.
What are amino acid derivatives?
Amino acid derivatives are compounds formed by chemical modification of amino acids, such as decarboxylation to form amines (e.g., histamine from histidine), hydroxylation, or conjugation. In the context of trace amines, derivatives like tyramine (from tyrosine) and tryptamine (from tryptophan) are important neuromodulators.
Why is histamine called biogenic amines?
Histamine is called a biogenic amine because it is synthesized in living organisms (biogenic) from an amino acid precursor and contains an amine group. Biogenic amines include neurotransmitters like dopamine and serotonin, as well as trace amines like tyramine and β-phenylethylamine.
Sourcing and Technical Support
In summary, 2-amino-5-methylphenol is a versatile intermediate for antihistamine precursors, but its value is defined by the control of trace amine impurities. By understanding the technical specifications, impurity profiles, and COA-driven acceptance criteria, procurement teams can secure a reliable supply that ensures high API yields and regulatory compliance. Our manufacturing process is optimized for consistency, and our technical support team is available to assist with method development and batch qualification. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.